http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003195207-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36 |
| filingDate | 2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45943b15cba52fdc44b3bc4fef6d6b6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6dda0002a359ee8678c2e2b898e0434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa59b26ec41e42a1730f537a4baa915d |
| publicationDate | 2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003195207-A1 |
| titleOfInvention | 3-Aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators |
| abstract | Substituted benzoxazine and 3,4-dihydrobenzoxazine derivatives possessing activity as estrogen receptor beta (ERĪ²) modulators are provided which have the structure of formula I n n n wherein the substitutents are as described herein. n In addition, a method is provided for preventing, inhibiting or treating the progression or onset of pathological conditions associated with the estrogen receptor and to pharmaceutical compositions containing such compounds. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006002989-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007077267-A1 |
| priorityDate | 2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 415.